Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis

Our analysis of a large international registry demonstrates that nonadherence with evidence-based secondary prevention therapies in patients with established atherothrombosis is associated with a significant increase in long-term adverse events, including mortality.